Mean platelet volume in obese adolescents with nonalcoholic fatty liver disease

Journal of Pediatric Endocrinology and Metabolism

Volumn 23, Issue 8, 2010, Pages 807-813

  Arslan, Nur ^a   Makay, Balahan ^a  

^a DOKUZ EYLUL UNIVERSITY   (Turkey)

Author keywords

Adolescents; Atherosclerosis; Insulin resistance; Mean platelet volume; Nonalcoholic fatty liver disease; Obesity

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL;

ADOLESCENT; ALCOHOL CONSUMPTION; ARTICLE; ATHEROSCLEROSIS; CHILD; CONTROLLED STUDY; DATA BASE; FEMALE; FOLLOW UP; HOMEOSTASIS; HUMAN; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; NONALCOHOLIC FATTY LIVER; OBESITY; PATIENT CODING; RETROSPECTIVE STUDY; SCHOOL CHILD; THROMBOCYTE ACTIVATION; THROMBOCYTE COUNT; THROMBOCYTE VOLUME;

ADOLESCENT; BIOLOGICAL MARKERS; BLOOD PLATELETS; BODY MASS INDEX; CELL SIZE; CHILD; CLINICAL CHEMISTRY TESTS; FATTY LIVER; FEMALE; HEMATOLOGIC TESTS; HUMANS; INSULIN RESISTANCE; MALE; OBESITY; PLATELET ACTIVATION; PLATELET FUNCTION TESTS; RETROSPECTIVE STUDIES;

EID: 77958526376     PISSN: 0334018X     EISSN: None     Source Type: Journal    
DOI: 10.1515/jpem.2010.130     Document Type: Article

References (38)

1. Chinn S, Rona RJ. Prevalence and trends in overweight and obesity in three cross sectional studies of British Children, 1974-94. BMJ 2001;322: 24-26.
2. Lobstein T, Frelut ML. Prevalence of overweight among children in Europe. Obes Rev 2003;4: 195-200.
3. Ogden CL, Carroll MD, Curtin LR, McDowell MA, Tabak CJ, Flegal KM. Prevalence of overweight and obesity in the United States, 1999-2004. JAMA 2006;295:1549-1555.
4. Manco M, Bottazzo G, DeVito R, Marcellini M, Mingrone G, Nobili V. Nonalcoholic fatty liver disease in children. J Am Coll Nutr 2008;27:667-676.
5. Arslan N, Büyükgebiz B, Oztürk Y, Cakmakçi H. Fatty liver in obese children: prevalence and correlation with anthropometric measurements and hyperlipidemia. Turk J Pediatr 2005;47:23-27.
6. Patton HM, Sirlin C, Behling C, et al (2006) Pediatric nonalcoholic fatty liver disease: a critical appraisal of current data and implications for future research. J Pediatr Gastroenterol Nutr 43:413-427.
7. Sathya P, Martin S, Alvarez F. Nonalcoholic fatty liver disease (NAFLD) in children. Curr Opin Pediatr 2002;14:593-600.
8. Sheth SG, Gordon FD, Chopra S. Nonalcoholic steatohepatitis. Ann Intern Med 1997;126:137-145.
9. Aygun C, Kocaman O, Sahin T, Uraz S, Eminler AT, Celebi A, Senturk O, Hulagu S. Evaluation of metabolic syndrome frequency and carotid artery intima-media thickness as risk factors for atherosclerosis in patients with nonalcoholic fatty liver disease. Dig Dis Sci 2008;53:1352-1357.
10. Kim HC, Kim DJ, Huh KB. Association between nonalcoholic fatty liver disease and carotid intimamedia thickness according to the presence of metabolic syndrome. Atherosclerosis 2009;204:521-525.
11. Pacifico L, Cantisani V, Ricci P, Osborn JF, Schiavo E, Anania C, Ferrara E, Dvisic G, Chiesa C.Nonalcoholic fatty liver disease and carotid atherosclerosis in children. Pediatr Res 2008;63:423-427.
12. Demircioǧlu F, Koçyiǧit A, Arslan N, Cakmakçi H, Hizli S, Sedat AT. Intima-media thickness of carotid artery and susceptibility to atherosclerosis in obese children with nonalcoholic fatty liver disease. J Pediatr Gastroenterol Nutr 2008;47:68-75.
13. Fan JG, Li F, Cai XB, Peng YD, Ao QH, Gao Y. Effects of nonalcoholic fatty liver disease on the development of metabolic disorders. J Gastroenterol Hepatol 2007;22:1086-1091.
14. Koebnick C, Getahun D, Reynolds K, Coleman KJ, Porter AH, Lawrence JM, Punyanitya M, Quinn VP, Jacobsen SJ. Trends in nonalcoholic fatty liver disease-related hospitalizations in US children, adolescents, and young adults. J Pediatr Gastroenterol Nutr 2009;48:597-603.
15. Shoelson SE, Herrero L, Naaz A. Obesity, inflammation, and insulin resistance. Gastroenterology 2007; 132:2169-2180.
16. Chavez-Tapia NC, Sanchez-Avila F, Vasquez-Fernandez F, Torres-Machorro A, Tellez-Avila FI, Uribe M. Non-alcoholic fatty-liver disease in pediatric populations. J Pediatr Endocrinol Metab 2007;20:1059-1073.
17. Dunn W, Schwimmer JB. The obesity epidemic and nonalcoholic fatty liver disease in children. Curr Gastroenterol Rep 2008;10:67-72.
18. Farrel GC, Teoh NC, McCuskey RS. Hepatic microcirculation in fatty liver disease. Anat Rec 2007;291:684-692.
19. Martin JF, Trowbridge EA, Salmon G, Plumb J. The biological significance of platelet volume: Its relationship to bleeding time, thromboxane B2 production and megakaryocyte nuclear DNA concentration. Thromb Res 1983;32:443-460.
20. Thompson CB, Eaton KA, Princiotta SM, Rushin CA, Valeri CR. Size dependent platelet subpopulations: relationship of platelet volume to ultrastructure, enzymatic activity, and function. Br J Haematol 1982;50:509-519.
21. Coban E, Özdoǧan M, Yazicioglu G, Akcit F. The mean platelet volume in patients with obesity. Int J Clin Pract 2005;59:981-982.
22. Coban E, Yilmaz A, Sari R. The effect of weight loss on the mean platelet volume in obese patients. Platelets 2007;18:212-216.
23. Toplak H, Wascher TC. Influence of weight reduction on platelet volume: different effects of a hypocaloric diet and a very low calorie diet. Eur J Clin Invest 1994;24:778-780.
24. Lebovitz HE. Insulin resistance - a common link between type 2 diabetes and cardiovascular disease. Diabetes Obes Metab 2006;8:237-249.
25. Stern MP. Diabetes and cardiovascular disease. The 'common soil' hypothesis. Diabetes 1995;44: 369-374.
26. Strauss RS. Childhood obesity. Pediatr Clin North Am 2002;49:175-201.
27. Quin SF, Gosink BB. Characteristic sonographic signs of hepatic fatty infiltration. Am J Roentgenol 1985;145:753-755.
28. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985;28:412-419.
29. Chu SG, Becker RC, Berger PB, Bhatt DL, Eikelboom JW, Konkle B, Mohler ER, Reilly MP, Berger JS. Mean platelet volume as a predictor of cardiovascular risk: a systematic review and meta-analysis. J Thromb Haemost Doi:10.1111/j.1538-7836.2009.03584.x
30. Lippi G, Filippozzi L, Salvagno GL, Montagnana M, Franchini M, Guidi GC, Targher G. Increased mean platelet volume in patients with acute coronary syndromes. Arch Pathol Lab Med 2009;133:1441-1443.
31. Sen N, Basar N, Maden O, Ozcan F, Ozlu MF, Gungor O, Cagli K, Erbay AR, Balbay Y. Increased mean platelet volume in patients with slow coronary flow. Platelets 2009;20:23-28.
32. Tavil Y, Sen N, Yazici HU, Hizal F, Abaci A, Cengel A. Mean platelet volume in patients with metabolic syndrome and its relationship with coronary artery disease. Thromb Res 2007;120:245-250.
33. Lizardi-Cervera J, Aguilar-Zapata D. Nonalcoholic fatty liver disease and its association with cardiovascular disease. Ann Hepatol 2009;Suppl 1:S40-S43.
34. Sewell R, Ibbotson RM, Philips R, Carson P. High mean platelet after myocardial infarction: is it due to consumption of small platelets? Br Med J 1984;289:1576-1578.
35. Coban E, Bostan F, Ozdogan M. The mean platelet volume in subjects with impaired fasting glucose. Platelets 2006;17:67-69.
36. Coban E, Kucuktag S, Basyigit S. Platelet activation in subjects with impaired glucose tolerance. Platelets 2007;18:591-594. (Pubitemid 350179041)
37. Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults. Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA 2001;285;2486-2497.
38. Demirtunc R, Duman D, Basar M. Effects of doxazosin and amlodipine on mean platelet volume and serum serotonin level in patients with metabolic syndrome: a randomised, controlled study. Clin Drug Investig 2007;27:435-441.